ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000663.1|Hopene_1 # 1 # 912 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.730	BGC0000663.1|Hopene_1 	1	912	+	Loose	500	25.7942	OXA-192	30.43	3001766	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACGGTCACCGACACGGCGCACGCCGTCGACCCGGAGCGCGGCACCCTCGCCAAGGCCGCCGACGAGAACTTCCCCGTCGCCCCCTTCTTCCTGCCCCGCGCCTGGCGCACCGACCTCATGGCCGTCTACGGCTTCGCCCGTCTCGTCGACGACATCGGCGACGGCGACCTCGCCCCGGGCGGAGCGGACGCCCGCCTGCTCGGCGTCCCCGAGGACCGCGCCGACGACCGACTGCTGATGCTGGACGCCTTCGAGGCGGACCTGCGTCGTGTCTTCGACGGCTCCGACGGTGCGCCCCGCCACCCGCTGCTGCGCCGTCTGGTGCCCACCGTGCGCCGCCGCGCGCTGACCCCCGAGCCCTTCCTCGGCCTGATCGCCGCCAACCGGCAGGACCAGCTGGTCGCACGGTACGAGACCTACGACGACCTCCTCGCCTACTGCGAGCTGTCCGCCAACCCCGTCGGCCGTCTCGTCCTCGCCGTCACCGGCACCTCGACCCCCGAACGGATCCGCCGCTCCGACGAGATCTGCACCGCCCTGCAGATCGTCGAGCACCTCCAGGACGTCGCCGAGGACCTCGGACGGGACCGGATCTACCTGCCCGCCGAGGACATGAAGCGCTTCCACGTCCAGGAGGCGGACCTCGCCGCGCCCAGCGCGAACGCCTCCGTGCGCGCGCTGATCGCCTACGAGGCCGCCCGCGCCCGCGACCTGCTGAATGAAGGCGCCCCCCTGGTGGGTAGCGTCCACGGCAGGCTGCGACTGCTCCTGGCGGGCTTCGTGGCGGGTGGCAGGGCGGCGCTGAACGCGATCGCCGCGGCGGATCACGACGTACTTCCCGGCCCGCCCAAGTCAGGCAAGGTCCACTTGCTGCGCGAGGCGGGCGTGGTCCTGCGAGGAGAGGGGTGA	MTVTDTAHAVDPERGTLAKAADENFPVAPFFLPRAWRTDLMAVYGFARLVDDIGDGDLAPGGADARLLGVPEDRADDRLLMLDAFEADLRRVFDGSDGAPRHPLLRRLVPTVRRRALTPEPFLGLIAANRQDQLVARYETYDDLLAYCELSANPVGRLVLAVTGTSTPERIRRSDEICTALQIVEHLQDVAEDLGRDRIYLPAEDMKRFHVQEADLAAPSANASVRALIAYEAARARDLLNEGAPLVGSVHGRLRLLLAGFVAGGRAALNAIAAADHDVLPGPPKSGKVHLLREAGVVLRGEG	MSKKNFILIFIFVILISCKNTEKTSNETTLIDNIFTNSNAEGTLVIYNLNDDKYIIHNKERAEQRFYPASTFKIYNSLIGLNEKAVKDVDEVFYKYNGEKVFLESWAKDSNLRYAIKNSQVPAYKELARRIGLEKMKENIEKLDFGNKNIGDSVDTFWLEGPLEISAMEQVKLLTKLAQNELPYPIEIQKAVSDITILEQTDNYTLHGKTGLADSENMTTEPIGWLVGWLEENNNIYVFALNIDNINSDDLAKRINIVKESLKALNLLK	112.64	gnl|BL_ORD_ID|1165|hsp_num:0	1269			621	759	cloxacillin; oxacillin; cefalotin
BGC0000663.1|Hopene_2 # 909 # 1859 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=3-4bp;gc_cont=0.737	BGC0000663.1|Hopene_2 	909	1859	+	Loose	1900	28.1054	TriC	31.71	3003681	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGATCGGGTCCGTGGAGTCGTCAGCGAACATGCCGGCACCGGTGCTCGCCGCCTACAGCTACTGCGAGGCCGTCACCGGTCAGCAGGCACGCAACTTCGCCCACGGCATCCGGCTGCTGCCCACGCCCAAGCGGCGGGCGATGTCCGCGCTGTACGCGTTCTCGCGCCGGGTCGACGACATCGGCGACGGAGTGCTGGCGGACGACGTCAAGGTCACCCGGCTGGACGAGACCCGGGCCGTGCTCGCCCGGATCCAGGACGGCGCGGTCGAGGAGGACGACACCGACCCGGTCGCCGTCGCCCTCGCCGACGCGGCCCGGCGGTTTCCCATCCCGCTCGGCGGCCTCGACGAGCTGATCGACGGCGTCCAGATGGACCTGCGCGGCGAGACCTACGAGACCTGGGACGACCTGAAGGTCTACTGCCGCTGCGTGGCGGGCGCCATCGGACGCCTCTCGCTCGGCGTCTTCGGCACCGAACCGGGGGCGCGCGGCGCCGAGCGCGCGCCCGAGTACGCCGACACGCTCGGGCTCGCGCTGCAGCTCACCAACATCCTGCGCGACGTCCGGGAGGACGCCGAGGGCGGGCGCACCTACCTGCCCGCCGACGACCTCGCCAAGTTCGGCTGCGCGGCCGGATTCAACGGCCCGACACCACCCGAGGGCTCCGACTTCGCGGGCCTCGTGCACTTCGAAGTGCGTCGGGCCCGCGCCCTTTTCGCCGAGGGCTACCGGCTGCTGCCCATGCTCGACCGGCGCAGCGGCGCCTGCGTGGCCGCCATGGCCGGCATCTACCGCCGTCTCCTGGACCGCATCGAGCGCGACCCCGAGGCCGTACTGCGCGGCCGGGTCTCCCTGCCGGGACGCGAGAAGGCGTACGTCGCCGTGCGCGGCCTGTCCGGCCTCGACGCCCGGCACGTCACCCGGCGGACCGTCAGGAGGCGCGCCTGA	MIGSVESSANMPAPVLAAYSYCEAVTGQQARNFAHGIRLLPTPKRRAMSALYAFSRRVDDIGDGVLADDVKVTRLDETRAVLARIQDGAVEEDDTDPVAVALADAARRFPIPLGGLDELIDGVQMDLRGETYETWDDLKVYCRCVAGAIGRLSLGVFGTEPGARGAERAPEYADTLGLALQLTNILRDVREDAEGGRTYLPADDLAKFGCAAGFNGPTPPEGSDFAGLVHFEVRRARALFAEGYRLLPMLDRRSGACVAAMAGIYRRLLDRIERDPEAVLRGRVSLPGREKAYVAVRGLSGLDARHVTRRTVRRRA	MKGGFNLSDWALRHQSLVWYLMAVSLVMGVFSYLNLGREEDPSFAIKTMVIQTRWPGATVDDTLEQVTDRIEKKLEELDSLDYVKSYTRPGESTVFVYLKDTTKAGDIPDIWYQVRKKISDIQGEFPQGIQGPGFNDEFGDVFGSVYAFTADGLDFRQLRDYVEKVRLDIRSVKDLGKVQMIGAQNEVIYLNFSTRKLAALGLDQRQVVQSLQAQNAVTPSGVVEAGPERISVRTSGNFRSEKDLQAVNLRVNDRFYRLSDLASISRDFVDPPTSLFRYKGEPAIGLAVAMKEGGNILEFGEALNARMQEITGELPVGVGVHQVSNQAQVVKKAVGGFTRALFEAVVIVLIVSFVSLGLRAGLVVACSIPLVLAMVFVFMEYTDITMQRVSLGALIIALGLLVDDAMITVEMMITRLELGDSLHDSATYAYTSTAFPMLTGTLVTVAGFVPIGLNASSAGEYTFTLFAVIAVALLLSWIVAVLFAPVIAVHILPKTLKHKSEQKKGRIAERFDSLLHLAMRRRWTTIFLTALLFGVSLFLMKFVQHQFFPSSDRPELLVDLNLPQNSSIHETRAVMDRLEATLKDDEDIDHWSAYVGEGAIRFYLPLDQQLQNNFYGQLVIVTKDLEARERVAARLRDRLRKDYVGISTYVQPLEMGPPVGRPIQYRVSGPQIDKVREYAMGLAGVLDGNPNIGDIVYDWNEPGKMLKIDIAQDKARQLGLSSEDVAQIMNSVVTGSAVTQVRDDIYLVNVIGRAEDSERGSLETLESLQIVTPSGTSIPLKAFAKVSYELEQPLVWRRDRKPTITVKASLRGEIQPTDLVARLAPEVKRFADGLPANYRIEVGGTVEESGKAEGPIAKVVPLMLFLMATFLMIQLQSVQKLFLVASVAPLGLIGVVAALLPTGTPMGFVAILGILALIGIIIRNSVILVTQIDAFEKDGKTPWEAVLEATHHRTRPILLTAAAASLGMIPIAREVFWGPMAYAMIGGIVAATLLTLIFLPALYVAWYRIPEPGR	31.13	gnl|BL_ORD_ID|2004|hsp_num:0	2194			1698	1821	triclosan
BGC0000663.1|Hopene_3 # 1859 # 2017 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.698	BGC0000663.1|Hopene_3 	1859	2017	+	Loose	1250	22.7126	mecA	33.33	3000617	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	ATGGACACACCGGGCACACTCGACACCCGGGACCCGTACAAAACCGGCGGCGGGCAGTGGCGGGCAACCCTGCGGTGGCGGTCGGCGTCCCTGACTGAGACGGTCAGCCGTACGCCGTTCAAACACCGCGGCGGCCGGACAGGGAAGGGCGCACCATGA	MDTPGTLDTRDPYKTGGGQWRATLRWRSASLTETVSRTPFKHRGGRTGKGAP	MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEVEMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKEDGMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSKKDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETKSRNYPLEKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVTIVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLALVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLDDKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFEKGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALENNGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGTAELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENGNKKYDIDE	7.78	gnl|BL_ORD_ID|1216|hsp_num:0	1321			1251	1332	methicillin
BGC0000663.1|Hopene_4 # 2014 # 3450 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.734	BGC0000663.1|Hopene_4 	2014	3450	+	Loose	700	26.5646	EreA2	35.38	3002826	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide esterase	ATGACGCAGGGCAAGGGCACGCGCGAGGGCGGAGTGCTCGCGGACGTCTCGGCCCTCGGCCCCGGCGGGCATGCCGTCGTGGTCGGCGGCGGACTCGCGGGGGTCACCACCGCGCTGGCACTGGCGGACGCCGGTGTGCGCGTCACCCTGCTCGAAGGACGCCCCCGGCTCGGCGGGCTCGCCTTCTCCTTCCAGCGCGGCGACCTCACCGTCGACAACGGCCAGCACGTGTACCTGCGCTGCTGCACCGCCTACCGGTGGTTCCTCGACCGGATCGGCGGAGCCGCGCTCGCACCGGTGCAGGAACGTCTCGACGTGCCCGTGGTCGACCTGGCGAGGACCGAGGGCAACCGGCTCGGCAGACTGCGGCGCGACGCGCTGCCCGTCCCCCTGCATCTGGGGCGCAGCCTCGCGACCTACCCGCACCTCTCCCTCGCCGAACGCGCCTCGGTGGGACGCGCCGCGCTCGCGCTCAAGGGGCTCGACCTCGCCGATCCGAGCCTGGACACCCAGGACTTCGGCAGCTGGCTGACCGCGCACGGTCAGTCGGCGCGTGCCGTCGAGGCCCTGTGGGACCTGGTCGGGGTCGCCACCCTCAACGCGGTCGCGGGCGACGCCTCGCTGGGGCTCGCCGCGATGGTGTTCAAGACCGGTCTGCTGTCCGACCCGGGAGCGGCCGACATCGGGTGGGCCCGTGTCCCGCTGGGCGAACTGCACGACCGGCTGGCCCGCAAGGCGCTCGACTCCGCGGGCGTCCGTACCGAGGTCCGTACACGCGTCACCTCCGTCTCCGTAAACGAGAACGGCGGCTGGAGCGTTCAGGTTCCCGGCGAGACGCTCGAAGCGGACGCCGTCGTCCTCGCCGTACCCCAGCGCGAGGCCCACGACCTGCTGCCGGACGGTGCGCTGGACGCCCCGGAAAATCTTCTGCGGATCGGCACCGCGCCGATCCTCAACATCCACGTGATCTACGACCGCAAGGTGCTCGGCACGCCGTTCCTCACGGCCCTCGGCACCCCGGTCCAGTGGGTGTTCGACCGCACCGAGGCCTCCGGGCTGAAGGAGGGTCAGTACCTGGCGCTGTCCCAGTCGACCGCGCAGAACGACATCGACGAGCCCGTGGCCGTGCTGCGCGAGCGGTACCTGCCCGAACTGGAGCGGCTGCTGCCGCGCACCCGGGGTGCCGAGGTGAAGGACTTCTTCGTGACCAGGGAGCGCACCGCCACGTTCGCCCCCGCCCCCGGCGTCGGGCGCCTCAGGCCCGGCGCCCGCACCAAGGCACCCGGCCTCTACCTGGCCGGAGCGTGGACCGCCACCGGGTGGCCCGCGACCATGGAGAGTGCGGTTCGCAGCGGTGTCGGGGCGGCGGCCGCCGCGCTCGGCGCCCTGGGCCGGTCCCGCGGCCTCCTTCCCGATTTCTTCGAGGAGGCGGCGTGA	MTQGKGTREGGVLADVSALGPGGHAVVVGGGLAGVTTALALADAGVRVTLLEGRPRLGGLAFSFQRGDLTVDNGQHVYLRCCTAYRWFLDRIGGAALAPVQERLDVPVVDLARTEGNRLGRLRRDALPVPLHLGRSLATYPHLSLAERASVGRAALALKGLDLADPSLDTQDFGSWLTAHGQSARAVEALWDLVGVATLNAVAGDASLGLAAMVFKTGLLSDPGAADIGWARVPLGELHDRLARKALDSAGVRTEVRTRVTSVSVNENGGWSVQVPGETLEADAVVLAVPQREAHDLLPDGALDAPENLLRIGTAPILNIHVIYDRKVLGTPFLTALGTPVQWVFDRTEASGLKEGQYLALSQSTAQNDIDEPVAVLRERYLPELERLLPRTRGAEVKDFFVTRERTATFAPAPGVGRLRPGARTKAPGLYLAGAWTATGWPATMESAVRSGVGAAAAALGALGRSRGLLPDFFEEAA	MTWRTTRTLLQPQKLEFNEFEILNPVVEGARIVGIGEGAHFVAEFSLARASLIRYFVERHDFNAIGLECGAIQASRLSEWLNSTAGAHELERFSDTLTFSLYGSVLIWVKSYLRESGRKLQLVGIDLPNTLNPRDDLAQLAEIIQVIDHLMKPHVDALTQLLTSIDGQSAVISSAKWGELETAQQEKAISGVTRLKLRLASLAPVLKNHVNSDFFRKASDRIESIEYTLETLRVMKAFFDGTSLEGDTSVRDSYMAGVVDGMVRANPDVRIILLAHNNHLQKTPVSFSGELTAVPMGQHLAEREEGDYRAIAFTHLGLTVPEMHFPSPDSPLGFSVVTTPADAIREDSVEQYVIDACGKEDSCLTLTDDPMEAKRMRSQSASVETNLSEAFDAIVCVPSAGKDSLVAL	117.16	gnl|BL_ORD_ID|1397|hsp_num:0	1518			735	927	erythromycin
BGC0000663.1|Hopene_5 # 3447 # 4583 # 1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=AGGAGG;rbs_spacer=3-4bp;gc_cont=0.730	BGC0000663.1|Hopene_5 	3447	4583	+	Loose	850	29.6462	OpmH	27.18	3003682	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAAAGCCGATCCGCGCGGGACCGGCTCCCGCACTCCCGGCACCGCAACTGGAGGAAAGACTGTGCCCACTGTGCCCCCGGCCCCGACGGCCGATCGACGGACCACGGTGGACGTGACCGCGCTTCTGGAGCGCGGCCGGACCCTGGCCACGCCGGTCCTGCGGGCGGCCGTCGACCGCCTGGCCCCTCCCATGGACACCGTCGCCGCCTACCACTTCGGCTGGATCGACGCCCAGGGCAACCCCGCGGACGGCGACGGTGGCAAGGCCGTCCGCCCCGCGCTCGCCGTGCTCTCCGCCGAGGTCACCGGCGCCGCCCCCGAGGTCGGCGTGCCCGGCGCGGTGGCCGTGGAACTGGTGCACAACTTCTCCCTCCTGCACGACGACCTGATGGACGGCGACGAGCAGCGCCGCCACCGCGACACCGTCTGGAAGGTGCACGGCCCCGCCCAGGCCATCCTGGTCGGCGACGCCCTGTTCGCCCTCGCCAACGAGGTGCTGCTCGAACTGGGCACCGTCGAGGCCGGGCGGGCCACCCGCCGCCTGACCAAGGCCAGCCGCTCCCTGATCGACGGTCAGGCCCAGGACATCTCCTACGAGCACCGCGACCGCGTCAGCGTCGAGGAGTGCCTGGAGATGGAGGGCAACAAGACCGGCGCCCTGCTCGCCTGCGCCAGCTCCATCGGCGCGGTGCTCGGCGGCGCCGACGAACGCACCGCCGACACCCTGGAGAAGTACGGCTACCACCTCGGTCTCGCCTTCCAGGCCGTCGACGACCTGCTCGGCATCTGGGGCGACCCGGACGCCACCGGCAAGCAGACCTGGAGCGACCTGCGCCAGCGCAAGAAGTCGCTGCCGGTCGTCGCCGCCCTCGCGGCCGGCGGGGCCGCTTCCGAGCGGCTCGGCGAGATCCTCACGGCCGACGCCAAGGCCAGCGACTTCGCGAACTTCTCCGAGGAGGAGTTCGCGGCCCGCGCCGCCCTCATCGAGGAAGCGGGCGGGCGGGAGTGGACCGCCGACGAGGCGCGTCGCCAGCACACCATCGCCATCGAAGCCCTCGACGCCGTCGACATGCCCGACCGGGTGCGGGACCGGTTCACGGCCCTCGCGGACTTCGTCGTCGTACGAAAGAGATGA	MKADPRGTGSRTPGTATGGKTVPTVPPAPTADRRTTVDVTALLERGRTLATPVLRAAVDRLAPPMDTVAAYHFGWIDAQGNPADGDGGKAVRPALAVLSAEVTGAAPEVGVPGAVAVELVHNFSLLHDDLMDGDEQRRHRDTVWKVHGPAQAILVGDALFALANEVLLELGTVEAGRATRRLTKASRSLIDGQAQDISYEHRDRVSVEECLEMEGNKTGALLACASSIGAVLGGADERTADTLEKYGYHLGLAFQAVDDLLGIWGDPDATGKQTWSDLRQRKKSLPVVAALAAGGAASERLGEILTADAKASDFANFSEEEFAARAALIEEAGGREWTADEARRQHTIAIEALDAVDMPDRVRDRFTALADFVVVRKR	MLRRLSLAAAVAAATGVAWAAQPTPLPTKTDLISVYKEAVDNNADLAAAQADYLARKEVVPQARAGLLPQLGAGARVGDTRIAFDERPATVKRNSQVVQATLSQPLFRADRWFQWQAAKETSDQARLEFSATQQDLILRSAETYFTVLRAQDNLATSKAEEAAFKRQLDQANERFDVGLSDKTDVLEAQASYDTARANRLIAEQRVDDAFQALVTLTNRDYSAIEGMRHTLPVVPPAPNDAKAWVDTAVQQNLRLLASNYAVNAAEETLRQRKAGHLPTLDAVAQYQKGDNDALGFANSAANPLVHYGKYVDERSIGLELNIPIYSGGLTSSQVRESYQRLNQSEQSREGQRRQVVQDTRNLHRAVNTDVEQVQARRQAIISNQSSLEATEIGYQVGTRNIVDVLNAQRQLYAAVRDYNNSRYDYILDTLRLKQAAGTLSPADLEALSAYLKQDYDPDKDFLPPDLAKAAAEQLQSKPRQQY	78.42	gnl|BL_ORD_ID|2005|hsp_num:0	2195			687	1248	triclosan
BGC0000663.1|Hopene_6 # 4700 # 6742 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.724	BGC0000663.1|Hopene_6 	4700	6742	+	Loose	710	27.335	cmeA	23.67	3000783	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; cephalosporin; fusidane antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACAGCGACGACCGACGGAAGCACCGGAGCCTCCCTGCGGCCCCTGGCAGCCTCGGCCAGCGACACCGACATCACGATCCCCGCCGCGGCGGCCGGGGTACCCGAAGCCGCCGCCCGCGCCACCCGGCGTGCCACCGACTTCCTGCTCGCCAAGCAGGACGCCGAGGGCTGGTGGAAGGGCGACCTCGAGACGAACGTCACGATGGACGCCGAGGACCTGCTCCTGCGTCAGTTCCTGGGCATCCAGGACGAGGAGACCACCCGCGCCGCCGCGCTGTTCATCCGCGGCGAGCAGCGCGAGGACGGCACCTGGGCCACCTTCTACGGCGGCCCCGGCGAACTGTCCACGACCATCGAGGCCTACGTCGCCCTCCGCCTGGCCGGCGACTCACCCGAGGCGCCCCACATGGCGCGGGCCGCGGAGTGGATCAGGTCCCGCGGCGGCATCGCCTCCGCCCGGGTCTTCACCCGGATCTGGCTGGCCCTGTTCGGCTGGTGGAAGTGGGACGACCTGCCCGAACTCCCGCCGGAGCTGATCTACTTCCCCACCTGGGTCCCGCTCAACATCTACGACTTCGGCTGCTGGGCCCGGCAGACCATCGTGCCGCTCACCATCGTCTCCGCGAAGCGGCCGGTGCGTCCCGCGCCGTTCCCGCTGGACGAACTGCACACCGACCCGGCCCGCCCCAACCCGCCACGCCCCCTGGCACCCGTGGCCAGCTGGGACGGCGCCTTCCAGCGCATCGACAAGGCCCTGCACGCCTACCGCAAGGTCGCCCCGCGCCGGCTGCGCCGGGCCGCGATGAACAGCGCCGCCCGCTGGATCATCGAGCGGCAGGAGAACGACGGCTGCTGGGGCGGCATCCAGCCGCCTGCGGTCTACTCGGTCATCGCCCTCTACCTGCTCGGCTACGACCTCGAACACCCCGTGATGCGCGCGGGACTGGAGTCGCTGGACCGTTTCGCCGTCTGGCGCGAGGACGGCGCCCGGATGATCGAGGCCTGCCAGTCCCCGGTGTGGGACACCTGCCTGGCCACCATCGCGCTGGCCGACGCGGGCGTGCCCGAGGACCACCCGCAGCTGGTGAAGGCCTCGGACTGGATGCTCGGCGAACAGATCGTGCGCCCCGGCGACTGGTCGGTGAAGCGCCCCGGACTCCCGCCCGGCGGCTGGGCGTTCGAGTTCCACAACGACAACTACCCCGACATCGACGACACCGCCGAGGTGGTCCTCGCCCTGCGCCGGGTCAGGCACCACGACCCGGAACGGGTGGAGAAGGCGATCGGGCGCGGGGTGCGCTGGAACCTCGGCATGCAGTCGAAGAACGGCGCCTGGGGCGCCTTCGACGTCGACAACACCAGCGCCTTCCCCAACCGGCTGCCGTTCTGCGACTTCGGCGAGGTCATCGACCCGCCGTCCGCGGACGTCACCGCGCACGTCGTCGAGATGCTCGCCGTCGAGGGCCTCGCCCACGACCCGCGCACCCGCCGCGGCATCCAGTGGCTGCTCGACGCCCAGGAGACGGACGGTTCGTGGTTCGGCCGCTGGGGCGTCAACTACGTCTACGGCACCGGTTCCGTGATCCCCGCGCTGACCGCGGCCGGACTGCCCACCTCGCACCCGGCCATCCGCCGGGCGGTGCGCTGGCTGGAGTCCGTCCAGAACGAGGACGGCGGCTGGGGCGAGGACCTGCGCTCCTACCGCTACGTCCGGGAGTGGAGCGGCCGGGGCGCCTCGACCGCCTCGCAGACCGGCTGGGCGCTGATGGCCCTGCTGGCGGCAGGGGAGCGGGACTCCAAAGCCGTGGAGCGCGGCGTCGCATGGCTCGCGGCCACCCAGCGGGAGGACGGCTCCTGGGACGAGCCCTACTTCACGGGCACCGGCTTCCCGTGGGACTTCTCCATCAACTACAACCTCTACCGCCAGGTCTTCCCGCTCACCGCTCTCGGCCGGTACGTCCACGGGGAGCCCTTCGCCAAGAAGCCCCGCGCGGCCGACGCCCCCGCCGAAGCCGCCCCGGCCGAGGTGAAGGGCAGCTGA	MTATTDGSTGASLRPLAASASDTDITIPAAAAGVPEAAARATRRATDFLLAKQDAEGWWKGDLETNVTMDAEDLLLRQFLGIQDEETTRAAALFIRGEQREDGTWATFYGGPGELSTTIEAYVALRLAGDSPEAPHMARAAEWIRSRGGIASARVFTRIWLALFGWWKWDDLPELPPELIYFPTWVPLNIYDFGCWARQTIVPLTIVSAKRPVRPAPFPLDELHTDPARPNPPRPLAPVASWDGAFQRIDKALHAYRKVAPRRLRRAAMNSAARWIIERQENDGCWGGIQPPAVYSVIALYLLGYDLEHPVMRAGLESLDRFAVWREDGARMIEACQSPVWDTCLATIALADAGVPEDHPQLVKASDWMLGEQIVRPGDWSVKRPGLPPGGWAFEFHNDNYPDIDDTAEVVLALRRVRHHDPERVEKAIGRGVRWNLGMQSKNGAWGAFDVDNTSAFPNRLPFCDFGEVIDPPSADVTAHVVEMLAVEGLAHDPRTRRGIQWLLDAQETDGSWFGRWGVNYVYGTGSVIPALTAAGLPTSHPAIRRAVRWLESVQNEDGGWGEDLRSYRYVREWSGRGASTASQTGWALMALLAAGERDSKAVERGVAWLAATQREDGSWDEPYFTGTGFPWDFSINYNLYRQVFPLTALGRYVHGEPFAKKPRAADAPAEAAPAEVKGS	MKLFQKNTILVLGVVFLLTACSKEEAPKIQMPPQPVTTMSAKSEDLPLNFTYPAKLVSDYDVIIKPQVSGVIVNKLFKAGDKVKRGQTLFIIEQAKFKASVDSAYGQALMAKATFENASKDFNRSEALFSKNAISQKEYDSSLATFNNAKASLASARAQLANARIDLDHTEIKAPFDGTIGDALVNIGDYVSTSTTELVRVTNLNPIYADFFISDTDKLNLVRNTQSGKWDLDSIHANLNLNGETVQGKLYFIDSVIDANSGTVKAKAVFDNNNSTLLPGAFATITSEGFIQKNGFKVPQIAIKQDQNDVYVLLVKNGKVEKSSVHISYQNNEYAIIDKGLQNGDKIILDNFKKIQVGSEVKEIGAQ	185.29	gnl|BL_ORD_ID|1089|hsp_num:0	1181			393	807	erythromycin; cefotaxime; fusidic acid
BGC0000663.1|Hopene_7 # 6742 # 7383 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.735	BGC0000663.1|Hopene_7 	6742	7383	+	Loose	900	26.1794	AAC(6')-Ie-APH(2'')-Ia bifunctional protein	34.29	3002597	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	aminoglycoside bifunctional resistance protein	ATGACCCCGCAGACCGGCCCGTCCCCGCTGCTGATCGCCTGCGCGCTCGGCATCGAGCACCTCGCCCTGCGCACCGGCGACCGCGCCGGCGCCGGCGGGCCGGTCACCGTCCTGCGCACCGGCATGGGTCCCAGGGCGGCCGAACGCTCGGTCACCCGGGTCCTCGCCGACCCGGCGCTCGAGGGCGCCGCCGTGCTCGCCACGGGCTTCTGCGCCGGACTCTCGCCCGGCATGCACCCCGGTGACCTGGTCGTCGCCGAGGAGACCCGGGACCCGCGCTCCACCGTCCCCTGCGTCGCGACCGACCGGCTCGTCAAGGAACTCGCGCGAGCCGTCCCCGGGCGCACCGTCCACACCGGGCCGCTGACCGGCTCGGACCACGTCGTCCGCGGCCCCGAACGCGCCGACCTGCTCGCGACCGGCGCGATCGCCGTGGACATGGAGTCCGCGGCCACGCTCCTGAGCGCCGTCCGCACGGGTCCGCGCCCGGTTGCGGCCGTCCGAGTGGTCGTGGACGCTCCAGAACACGAACTCGTCCGGATCGGCACCGTGCGCGGTGGAATATCGGCCTTCCGTGTTCTTCGATCCGTTCTTCCCGCATTTTTCGAATGGCACCGTTCTTTGTTGCTTCCCCGGAGGTGA	MTPQTGPSPLLIACALGIEHLALRTGDRAGAGGPVTVLRTGMGPRAAERSVTRVLADPALEGAAVLATGFCAGLSPGMHPGDLVVAEETRDPRSTVPCVATDRLVKELARAVPGRTVHTGPLTGSDHVVRGPERADLLATGAIAVDMESAATLLSAVRTGPRPVAAVRVVVDAPEHELVRIGTVRGGISAFRVLRSVLPAFFEWHRSLLLPRR	MNIVENEICIRTLIDDDFPLMLKWLTDERVLEFYGGRDKKYTLESLKKHYTEPWEDEVFRVIIEYNNVPIGYGQIYKMYDELYTDYHYPKTDEIVYGMDQFIGEPNYWSKGIGTRYIKLIFEFLKKERNANAVILDPHKNNPRAIRAYQKSGFRIIEDLPEHELHEGKKEDCYLMEYRYDDNATNVKAMKYLIEHYFDNFKVDSIEIIGSGYDSVAYLVNNEYIFKTKFSTNKKKGYAKEKAIYNFLNTNLETNVKIPNIEYSYISDELSILGYKEIKGTFLTPEIYSTMSEEEQNLLKRDIASFLRQMHGLDYTDISECTIDNKQNVLEEYILLRETIYNDLTDIEKDYIESFMERLNATTVFEGKKCLCHNDFSCNHLLLDGNNRLTGIIDFGDSGIIDEYCDFIYLLEDSEEEIGTNFGEDILRMYGNIDIEKAKEYQDIVEEYYPIETIVYGIKNIKQEFIENGRKEIYKRTYKD	44.47	gnl|BL_ORD_ID|4823|hsp_num:0	1814			387	492	dibekacin; amikacin; sisomicin; netilmicin; kanamycin A; tobramycin; gentamicin A; 2'-N-ethylnetilmicin; 5-episisomicin; gentamicin
BGC0000663.1|Hopene_9 # 8417 # 9571 # 1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.703	BGC0000663.1|Hopene_9 	8417	9571	+	Loose	750	25.409	LRA-10	38.46	3002489	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	class C LRA beta-lactamase	GTGACCGCCATCCCCTTGGGGCTCCCCGGGGTACCGGTCCGGCCGATCGCCGAGCGGCGCGTGTCGCGGCGGATCCAGGTCGGGCCGGTGGCGGTCGGGGGCGGGGCTCCGGTGTCGGTGCAGTCGATGACGACCACCCGTACGTCCGACATCGGGGCCACGCTCCAGCAGATCGCCGAGCTGACGGCGTCGGGCTGCCAGATCGTCCGGGTGGCCTGTCCCACCCAGGACGACGCCGACGCGCTGCCCGTCATCGCGAGGAAGTCGCAGATCCCGGTGATCGCGGACATCCACTTCCAGCCCAAGTACGTCTTCGCCGCGATCGAGGCCGGCTGCGCGGCGGTCCGGGTGAACCCGGGCAACATCAAGCAGTTCGACGACAAGGTCAAGGAGATCGCCAAGGCGGCGAAGGACCACGGCACGCCCATCCGCATCGGTGTGAACGCCGGCTCCCTCGACCGCCGCCTGCTCCAGAAGTACGGCAGGGCGACCCCCGAGGCCCTCGCCGAGTCCGCCCTCTGGGAGGCGTCGCTCTTCGAGGAGCACGACTTCCGCGACATCAAGATCTCGGTCAAGCACAACGACCCGGTCGTCATGGTCGAGGCCTACCGGCAACTCGCCGCCCAGTGCGACTACCCGCTGCACCTGGGGGTGACGGAGGCCGGGCCCGCGTTCCAGGGCACCATCAAGTCCGCCGTCGCCTTCGGCGCGCTGCTCTCGCAGGGCATCGGCGACACCATCCGGGTGTCGCTCAGCACCCCGCCGGTCGAGGAGATCAAGGTCGGCATCCAGATCCTGGAGTCGCTGAACCTGCGCCAGCGCGGCCTGGAGATCGTCTCCTGCCCGTCCTGCGGCCGCGCCCAGGTCGACGTCTACAAGCTGGCCGAGGAGGTCACCGCCGGGCTGGAGGGCATGGAGGTGCCGCTGCGCGTGGCCGTCATGGGCTGCGTCGTCAACGGCCCCGGTGAGGCCCGCGAGGCGGACCTCGGCGTCGCCTCCGGCAACGGCAAGGGGCAGATCTTCGTCAAGGGCGAGGTCGTCAAGACCGTGCCCGAGTCGAAGATCGTGGAGACCCTCATCGAGGAGGCGATGAGGATCGCGGAGCAGATGGAGAAGGACGGCGCCTCGGGGGCGCCGGCCGTCACCGTGAGCTGA	MTAIPLGLPGVPVRPIAERRVSRRIQVGPVAVGGGAPVSVQSMTTTRTSDIGATLQQIAELTASGCQIVRVACPTQDDADALPVIARKSQIPVIADIHFQPKYVFAAIEAGCAAVRVNPGNIKQFDDKVKEIAKAAKDHGTPIRIGVNAGSLDRRLLQKYGRATPEALAESALWEASLFEEHDFRDIKISVKHNDPVVMVEAYRQLAAQCDYPLHLGVTEAGPAFQGTIKSAVAFGALLSQGIGDTIRVSLSTPPVEEIKVGIQILESLNLRQRGLEIVSCPSCGRAQVDVYKLAEEVTAGLEGMEVPLRVAVMGCVVNGPGEAREADLGVASGNGKGQIFVKGEVVKTVPESKIVETLIEEAMRIAEQMEKDGASGAPAVTVS	MAIAILSSCFAPLASRAADDSARIRAIVDQAIRPVMAEHDVPGMAVAVTVDGQPFVFNYGVASRESNTPVSDATLFELGSISKTFAATLASYAQVTGKLSLDDHPGKYMPQLKGSAIDKATLLNLGTYTAGGLPLQFPDDVSDQQMASYFQHWKPKAAPGVQRTYSNPSLGLFGHLTSLALKSRFTDALETNVLTQMGMKSTYVHVPQSAMANYAWGYDQANKPGRMNPGVLADGIYGIRSTAADMIRYVQANIAPGKLETPLRRAVEGTHVGYFKVGGMVQGLGWEQYPYPVSLQQLQAGNSTTMAWEANPAQKLTPPSVPSGATLFNKTGSTSRFGAYVAFVPEKKIGIVILANKNIPGPDRIKAAHAILEQL	102.40	gnl|BL_ORD_ID|1915|hsp_num:0	2119			924	1077	
BGC0000663.1|Hopene_10 # 9597 # 11567 # 1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.726	BGC0000663.1|Hopene_10 	9597	11567	+	Loose	1500	27.335	rphA	39.22	3000444	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic inactivation	rifampin phosphotransferase	GTGACGATTCTGGAGAACATCCGGGGACCACGCGACCTGAAGGCGCTGTCCGAGGCGGAACTCGGTGAACTGTCCGACGAGATACGTGACTTCCTGGTGCACGCGGTCGCCCGCACCGGCGGTCACCTCGGACCCAACCTCGGCGTGGTGGAACTCACCGTCGCCCTGCACCGGGTCTTCGAGTCGCCGGACGACCGCATCCTGTGGGACACCGGCCATCAGAGCTATGTGCACAAACTCCTGACCGGACGTCAGGACTTCTCCAAGCTGCGGAGCAAGGGCGGCCTTTCCGGCTACCCCTCGCGCGAGGAGTCCGCGCACGACGTCATCGAGAACAGCCACGCCTCCACCGTCCTCGGCTGGGCCGACGGCCTCGCCAAGGCCCGCCAGGTGCAGGGGGAGCGCAGCCACGTCGTCGCCGTCATCGGTGACGGCGCGCTCACCGGCGGCATGGCCTGGGAGGCGCTGAACAACATCGCGGCGGCCAGGGACCGGCCGCTGATCATCGTCGTCAACGACAACGAACGCTCGTACGCGCCGACCATCGGCGGCCTCGCCAACCACCTGGCGACCCTGCGCACCACCGACGGCTACGAGCGGGCCCTGGCCTGGGGCAAGGACGTGCTCCAGCGCACGCCCGTGGTGGGCCACACCGTCTACGAGGCCCTGCACGGCGCCAAGAAGGGCTTCAAGGACGCCTTCGCCCCGCAGGGGCTCTTCGAGGACCTGGGACTGAAGTACCTCGGTCCGATCGACGGGCACGACATCGGCGCCGTCGAGTCGGCGCTCCGCCGCGCGAAGCGCTTCCACGGCCCGGTGCTCGTGCACTGCCTCACCGAGAAGGGCCGCGGCTACGAGCCCGCCCTGCGCGACGAGGAGGACCACTTCCACACGGTCGGCGTGATGGACCCGCTCACCTGCGAGCCGCTCGGCCCGGCGGGCGGGCCGTCCTGGACCTCCGTGTTCGGTGAGGAGATCGTCCGGATCGGCGAGGAGCGCGCGGACGTGGTGGCGATCACCGCGGCCATGCTGCACCCGGTCGGTCTCGCCCCTTTCGCCGAACGGTTCCCCGACCGCGTCTGGGACGTCGGCATCGCCGAGCAGCACGCCGCCGTCTCCGCCGCCGGCCTCGCCACCGGCGGACTGCACCCGGTCGTCGCCGTCTACGCCACCTTCCTCAACCGCGCCTTCGACCAGCTCCTGATGGACGTGGCCCTGCACCGCTGCGGCGTCACCTTCGTCCTGGACCGGGCCGGCGTCACCGGCGTCGACGGCGCCTCGCACAACGGCATGTGGGACATGTCCGTCCTCCAGGTCGTCCCCGGACTGCGGATCGCCGCCCCGCGCGACGCCGACCAGCTGCGCACCCAGCTGCGCGAGGCGGTCGCCGTGGACGACGCGCCGACGCTGCTGCGCTTCCCGAAGGAGTCCGTCGGCCCCGCCGTGCCCGCCGTCGACCGGATCGGCGGCCTGGACGTCCTGCACACCGCCGACCGGTCCGAGGTGCTGCTCGTGGCGGTGGGCGTGATGGCACCCGTCTGCCTCGGGGCCGCCGAACTCCTCGAGGCCCGCGGCATCGGCTGCACCGTCGTCGACCCGCGCTGGGTCAAGCCGGTCGACCCGGCGCTCGCACCGCTCGCGGCCCGGCACCGGCTGGTCGCCGTGGTCGAGGACAACAGCCGGGCCGCCGGGGTCGGTTCCGCGGTGGCGCTGGCGCTCGGCGACGCCGAGGTCGACGTCCCCGTGCGCCGCTTCGGCATCCCCGAGCAGTTCCTCGCGCACGCCAAGCGCGCCGAGGTGCTCGCGGACATCGGCCTCACCCCGGTCGACGTCGCCGGGCGGATCGCCGCGAGTCTGGCCCTCGCCGAGCCGGCCGGGGACCGGGCGGGTGGACCGGCAGTGGAACAGCCCGGCGACGGACGGATGTCCGGCGACGGACGGATCGTCATGCCAGCGCAAGGAGAGAACTGA	MTILENIRGPRDLKALSEAELGELSDEIRDFLVHAVARTGGHLGPNLGVVELTVALHRVFESPDDRILWDTGHQSYVHKLLTGRQDFSKLRSKGGLSGYPSREESAHDVIENSHASTVLGWADGLAKARQVQGERSHVVAVIGDGALTGGMAWEALNNIAAARDRPLIIVVNDNERSYAPTIGGLANHLATLRTTDGYERALAWGKDVLQRTPVVGHTVYEALHGAKKGFKDAFAPQGLFEDLGLKYLGPIDGHDIGAVESALRRAKRFHGPVLVHCLTEKGRGYEPALRDEEDHFHTVGVMDPLTCEPLGPAGGPSWTSVFGEEIVRIGEERADVVAITAAMLHPVGLAPFAERFPDRVWDVGIAEQHAAVSAAGLATGGLHPVVAVYATFLNRAFDQLLMDVALHRCGVTFVLDRAGVTGVDGASHNGMWDMSVLQVVPGLRIAAPRDADQLRTQLREAVAVDDAPTLLRFPKESVGPAVPAVDRIGGLDVLHTADRSEVLLVAVGVMAPVCLGAAELLEARGIGCTVVDPRWVKPVDPALAPLAARHRLVAVVEDNSRAAGVGSAVALALGDAEVDVPVRRFGIPEQFLAHAKRAEVLADIGLTPVDVAGRIAASLALAEPAGDRAGGPAVEQPGDGRMSGDGRIVMPAQGEN	MSGRLVVDLQDVDAAGLAEVGGKGAHLGELSRIDGVRVPSGFCVTTHAFRRIMAEAPESGELLDRLSRVDEGDQEAVRSLAARLRQVVGATPLPDEVAAAVTGALARHGERSAYAVRSSATAEDLPTASFAGQQDTYLNVVGTEEILRHVSRCWASLFTERAVTYRGRQGVDHRTVHMGVVVQRMVVPRASGILFTADPVTGDRRTATVDAGFGLGEALVSGLVDPDVLTVRHGEVVARTIAAKRRALHAVQGGGTRETPIEERRQREPVLTDDQAVELVALGRRIEAHFGSPQDIEWCLDDDGFHIVQSRPITTLFPVPERDDDVFRVYLSVGHQQMMTDAMKPLGLSMWRLTALAPMYEAGGRLFVDATARLAVPGSRATLLDVVGRGDPLTRDALETVLENGEFEPTPAETDGGAPPAGDGAEPDEADPSIVTELIERSRRSLAELEREIGTKSGPALFAFLREAFEEHKRVVGDPLNIRAIMAGMEATWWLNDRLEEWLGEKNAADTLTLSAPDNVTSEMGLELLDVADVVRTHPEVVAFLEGVEDDGFLDELPKVPGGAEARDAFEAYLDRYGMRCVGEIDITXPPVRERPSALVPVVLDHVRAFGPGAAARRFEDGRRRALAKEREVLERLRDLPDGERRADAARRMIRQVRAFAGYREYPKYAIVSRSFVYRQALLREADELVRAGVLADREDVHYLTFDEFEEAVRVRRVDERLVRRRKDAFRSYQALTPPRVLTSEGVALSGAYRRDDVPEGALAGLAVSAGTVEGRARVVLDMAEADLEAGDILVTRFTDPSWSPLFVGIAGLVTEVGGLMTHGAVIAREYGLAAVVGVERATRLIRDGQRIRVHGTEGYIELLS	75.84	gnl|BL_ORD_ID|890|hsp_num:0	910			1776	1908	rifampin; rifaximin; rifabutin; rifapentine
BGC0000663.1|Hopene_12 # 13027 # 13641 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.771	BGC0000663.1|Hopene_12 	13027	13641	+	Loose	500	28.8758	mecC-type BlaZ	27.06	3005097	protein homolog model	n/a	n/a	penam	antibiotic inactivation	BlaZ beta-lactamase	ATGAGCTCCTCCGAGACCGGCCCCGCCGAGGGGGCGGTCGCCGCCGTCGCGCCCCAGCTGCGTGAGCTGCGGCGGCGGGCCGCCCTCACCCTGGAGGCCGCCGCCCGCGCCGCAGGGCTCTCGCCCGCCCACCTCTCCCGCCTGGAGACCGGGCAGCGCCAGCCCTCGCTGCCGATGCTGCTCTCCCTCGCCCGGGTCTACGGTACGACCGTCGCCGAGCTGCTGGGCGAGTCGGCCGCGGACCGGGACGCCGTCGTGCGCGCCGCCGACATGGAACCCACCGCCGCGGGCGGCTGGACGTACTGGCGGGCCGGAGCGCCGGGCCGCGGCATGCAGGCCCTGCGCGTCCAGGTTCCGTACGGCTCCCAGGGCGACGTCGTGCGGGTGCACCCCGGCGAGGAGTGGCTGCACGTCCTGCGGGGCCGGCTGCGACTGCGCCTCGGGGACACCGAGCACCGGCTCACCGCGGGGGACAGCGCCCACTTCGACTCGATGACCCCGCACCGGATCGCCGCGCAGGACCCCGACGGGGTCGAGCTGCTGTTCGTCCACACCCTGCTGCAGAGCCCGACGGCCGCCCTGTGCCTCGGCCCGACCCCTGGAGAGACGCCATGA	MSSSETGPAEGAVAAVAPQLRELRRRAALTLEAAARAAGLSPAHLSRLETGQRQPSLPMLLSLARVYGTTVAELLGESAADRDAVVRAADMEPTAAGGWTYWRAGAPGRGMQALRVQVPYGSQGDVVRVHPGEEWLHVLRGRLRLRLGDTEHRLTAGDSAHFDSMTPHRIAAQDPDGVELLFVHTLLQSPTAALCLGPTPGETP	MKKLIILVVLALILSACNSKNSTNNDIEKIEKKYGANVGMYALNTQNGKELSFNENKRFAYASTLKTISSAMLLEQTPYNKLDKKIHINKDDIVPYSPVLEKYIGKEITLKKLIEATMLFSDNTANNKIIDELGGYGQVKTKLIDLGDTTTHPSRKEPDLNFYSPKDKRDTSTPLAYGKTLKKLIADGDLSKANKDFLLNLMFKNKSGDTLIKDGAPSNFKVMDKSGQALTYGSRNDVAFVYPDGQDKPIILVIFTNKDRKDGKPNDKIVSEVAEIVLKNINE	72.08	gnl|BL_ORD_ID|2812|hsp_num:0	3829			501	729	penicillin
BGC0000663.1|Hopene_13 # 13638 # 13757 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.642	BGC0000663.1|Hopene_13 	13638	13757	+	Loose	500	21.1718	mphA	43.48	3000316	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGAGCACCATGCAGGAGAAGTTCCCGCGCGCCCTGTGGGTGCGGCTGATCGTCTACATCGCCCTGGGGCACGTCTTCGGCGGCTTCCTCTACCTGCTGTTCGAGGTGGGCGCCAAGTAG	MSTMQEKFPRALWVRLIVYIALGHVFGGFLYLLFEVGAK	MTVVTTADTSQLYALAARHGLKLHGPLTVNELGLDYRIVIATVDDGRRWVLRIPRRAEVSAKVEPEARVLAMLKNRLPFAVPDWRVANAELVAYPMLEDSTAMVIQPGSSTPDWVVPQDSEVFAESFATALAALHAVPISAAVDAGMLIRTPTQARQKVADDVDRVRREFVVNDKRLHRWQRWLDDDSSWPDFSVVVHGDLYVGHVLIDNTERVSGMIDWSEARVDDPAIDMAAHLMVFGEEGLAKLLLTYEAAGGRVWPRLAHHIAERLAFGAVTYALFALDSGNEEYLAAAKAQLAAAE	12.96	gnl|BL_ORD_ID|1139|hsp_num:0	1243			771	840	erythromycin; roxithromycin; telithromycin; clarithromycin; azithromycin; dirithromycin; oleandomycin
